Financhill
Back

Viridian Therapeutics, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRDN is experiencing selling pressure, which indicates risk of future bearish movement.

Viridian Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 31.59 Buy
20-day SMA: 30.03 Buy
50-day SMA: 25.47 Buy
200-day SMA: 18.11 Buy
8-day EMA: 31.14 Buy
20-day EMA: 25.81 Buy
50-day EMA: 15.69 Buy
200-day EMA: 5 Buy

Viridian Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.6 Buy
Relative Strength Index (14 RSI): 68.29 Buy
Chaikin Money Flow: -581301 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.04 - 31.7) Buy
Bollinger Bands (100): (17.21 - 26.51) Buy

Viridian Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Viridian Therapeutics, Inc. Stock

Is Viridian Therapeutics, Inc. Stock a Buy?

VRDN Technical Analysis vs Fundamental Analysis

Sell
47
Viridian Therapeutics, Inc. (VRDN) is a Sell

Is Viridian Therapeutics, Inc. a Buy or a Sell?

Viridian Therapeutics, Inc. Stock Info

Market Cap:
3.1B
Price in USD:
32.02
Share Volume:
673.8K

Viridian Therapeutics, Inc. 52-Week Range

52-Week High:
33.34
52-Week Low:
9.90
Sell
47
Viridian Therapeutics, Inc. (VRDN) is a Sell

Viridian Therapeutics, Inc. Share Price Forecast

Is Viridian Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Viridian Therapeutics, Inc.

Is Viridian Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.

Technical Analysis of Viridian Therapeutics, Inc.

Should I short Viridian Therapeutics, Inc. stock?

* Viridian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.